Respiratory Diseases
Breath biomarkers could lead to non-invasive detection and monitoring for respiratory diseases
FIND OUT MOREPublication: Biomarkers of stress in lungs
A study of ultramarathon runners used Breath Biopsy to uncover markers of physical lung stress and injury caused by extreme exercise.
READ THE PAPERQuick Start Guide: Incorporate Breath Analysis into Respiratory Disease Research
Read our short document detailing the powerful potential of breath analysis in respiratory disease research, what data we have, and how Owlstone Medical can help.
DOWNLOAD NOWWhitepaper: Examining candidate breath biomarkers for kidney disease
Application of Breath Volatile Organic Compounds (VOCs) in Asthma
VIEW WHITEPAPERCase study: using the VOC Atlas for biomarker development
Breath VOC biomarkers for Cystic Fibrosis – steps towards the development of bacterial infection biomarkers for clinical use
READ CASE STUDYChronic respiratory diseases affect over 500M people worldwide and the annual cost of treatment in the US alone is almost $60B.
Although these diseases are common, diagnosis of respiratory diseases is complex as the symptoms experienced overlap considerably, and are driven by multiple subtypes with different underlying biology.
Breath is in direct contact with the respiratory tract, and so is especially enriched for volatile organic compounds (VOCs) originating from respiratory processes. Breath therefore offers a unique roster of potential biomarkers that can be collected non-invasively. Volatile compounds in exhaled breath have repeatedly shown promise in differentiating respiratory disease subtypes such as asthma. Some of these VOCs originate directly from the underlying inflammatory responses that cause these diseases, making them especially reliable indicators for respiratory disease diagnosis.
Case Studies
A detailed look at some of the research studies investigating biomarkers for different types respiratory diseases.
Breath VOC biomarkers for Cystic Fibrosis – steps towards the development of bacterial infection biomarkers for clinical use
VOC biomarkers indicative of Eosinophilic Inflammation in Asthma
FURTHER READING
Other recommended reading:
- DOCUMENT: Quick Start Guide: Incorporating Breath Analysis into Respiratory Disease Research
- PAPER: EMBER researchers analyze exhaled breath metabolites and distinct diagnostic signatures for acute cardiorespiratory breathlessness
- POSTER: Biomarkers of stress in lungs – A study of ultramarathon runners used Breath Biopsy to uncover markers of physical lung stress and injury caused by extreme exercise.
- REVIEW: ReCIVA is an optimal sampling solution – A systematic review by Azim et al. identifies ReCIVA as an optimal solution for clinical utility in breath collection.
- PAPER: VOCs, lung microbiome and COPD – Results from an early Breath Biopsy study with GSK examining VOCs on breath for insights into the lung microbiome in COPD patients.
Blog
Articles published on our blog related to respiratory diseases.